Skip to search formSkip to main contentSkip to account menu

asimadoline

Known as: N-methyl-N--(1-phenyl-2-(3-hydroxypyrrolidin-1-yl)ethyl)-2,2-diphenylacetamide hydrochloride 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

AcetamidesPyrrolidines

Narrower (1)

EMD 61753

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Advances in Achieving Opioid Analgesia Without Side Effects
Opioids are the most effective drugs for the treatment of severe pain, but they also cause addiction and overdose deaths, which… 
Highly Cited
2008
Highly Cited
2008
Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome
Background  In models of irritable bowel syndrome (IBS), asimadoline, a kappa‐opioid agonist, improves pain and abnormal bowel… 
Review
2008
Review
2008
Novel pharmacology: asimadoline, a κ‐opioid agonist, and visceral sensation
Abstract  Asimadoline is a potent κ‐opioid receptor agonist with a diaryl acetamide structure. It has high affinity for the… 
Highly Cited
2008
Highly Cited
2008
Novel D-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral kappa-opioid receptors.
Highly Cited
2008
Highly Cited
2008
2-Methoxymethyl-Salvinorin B Is a Potent κ Opioid Receptor Agonist with Longer Lasting Action in Vivo Than Salvinorin A
Salvinorin (Sal) A is a naturally occurring, selective κ opioid receptor (KOPR) agonist with a short duration of action in vivo… 
Highly Cited
2006
Highly Cited
2006
Gateways to clinical trials.
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the… 
Highly Cited
2004
Highly Cited
2004
Effect of asimadoline, a κ opioid agonist, on pain induced by colonic distension in patients with irritable bowel syndrome
Background : Visceral hypersensitivity plays a major role in irritable bowel syndrome pathophysiology. Opioid κ receptors on… 
Highly Cited
2003
Highly Cited
2003
Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans.
To compare the effects of the kappa-opioid agonist asimadoline and placebo on visceral sensation and gastrointestinal (GI) motor… 
Highly Cited
1999
Highly Cited
1999
Role of blood‐brain barrier P‐glycoprotein in limiting brain accumulation and sedative side‐effects of asimadoline, a peripherally acting analgaesic drug
Studies with knockout mice lacking mdr1a P‐glycoprotein (P‐gp) have previously shown that blood‐brain barrier P‐gp is important… 
1999
1999
Involvement of substance P in the anti‐inflammatory effects of the peripherally selective κ‐opioid asimadoline and the NK1 antagonist GR205171
We have previously shown that kappa‐opioids have antiarthritic properties. In this study, using two differently acting drugs (the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)